Daniil Gataulin
Stock Analyst at Chardan Capital
(4.70)
# 158
Out of 5,056 analysts
119
Total ratings
59.26%
Success rate
34.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QURE uniQure | Maintains: Buy | $53 | $30.12 | +75.96% | 10 | Nov 11, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $51 | $18.90 | +169.84% | 9 | Nov 11, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $35 | $8.66 | +304.16% | 6 | Nov 11, 2025 | |
| IRD Opus Genetics | Maintains: Buy | $9 | $1.92 | +368.75% | 2 | Nov 7, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $21 | $11.49 | +82.77% | 3 | Nov 5, 2025 | |
| KOD Kodiak Sciences | Maintains: Neutral | $14 | $20.25 | -30.86% | 3 | Oct 6, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $4.63 | +115.98% | 2 | Sep 30, 2025 | |
| OCGN Ocugen | Maintains: Buy | $7 | $1.34 | +422.39% | 14 | Sep 19, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $11.60 | +348.28% | 13 | Sep 8, 2025 | |
| OTLK Outlook Therapeutics | Maintains: Neutral | $3 | $1.28 | +134.38% | 10 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 | $14.46 | +321.85% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $4.30 | +667.44% | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $7.41 | +102.57% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $1.72 | +132.56% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $11.99 | +125.19% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.83 | - | 5 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $0.79 | +27,783.40% | 1 | Mar 7, 2024 |
uniQure
Nov 11, 2025
Maintains: Buy
Price Target: $53
Current: $30.12
Upside: +75.96%
Oculis Holding AG
Nov 11, 2025
Maintains: Buy
Price Target: $51
Current: $18.90
Upside: +169.84%
MeiraGTx Holdings
Nov 11, 2025
Maintains: Buy
Price Target: $35
Current: $8.66
Upside: +304.16%
Opus Genetics
Nov 7, 2025
Maintains: Buy
Price Target: $9
Current: $1.92
Upside: +368.75%
Ocular Therapeutix
Nov 5, 2025
Maintains: Buy
Price Target: $21
Current: $11.49
Upside: +82.77%
Kodiak Sciences
Oct 6, 2025
Maintains: Neutral
Price Target: $14
Current: $20.25
Upside: -30.86%
Zura Bio
Sep 30, 2025
Maintains: Buy
Price Target: $10
Current: $4.63
Upside: +115.98%
Ocugen
Sep 19, 2025
Maintains: Buy
Price Target: $7
Current: $1.34
Upside: +422.39%
REGENXBIO
Sep 8, 2025
Maintains: Buy
Price Target: $52
Current: $11.60
Upside: +348.28%
Outlook Therapeutics
Aug 28, 2025
Maintains: Neutral
Price Target: $3
Current: $1.28
Upside: +134.38%
Aug 15, 2025
Maintains: Buy
Price Target: $61
Current: $14.46
Upside: +321.85%
Aug 13, 2025
Maintains: Buy
Price Target: $33
Current: $4.30
Upside: +667.44%
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $7.41
Upside: +102.57%
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $1.72
Upside: +132.56%
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $11.99
Upside: +125.19%
Jul 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $3.83
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $0.79
Upside: +27,783.40%